Study aims to determine whether MKK4 inhibitor c
Browsing: All news
Category Added in a WPeMatico Campaign
Led by figures from Oxford, Genomics England and
Companies join forces to discover and develop ne
Company’s latest product continuously monitors
Neurotech firm Somnee secures funding to scale p
Shift Bioscience identifies potent, pluripotency
New consumer longevity brand to support company’s clinical development of therapeutics based on proprietary resveratrol delivery platform. Clinical stage biotech Jupiter Neurosciences has officially launched a new line of consumer supplements designed to support health and performance, broadening its focus…
NFX General Partner Omri Drory wonders why more
Preclinical data suggest Telomir’s oral drug m
RLS-1496 enters Phase 1 aiming to modulate GPX4